ADC Therapeutics (ADCT) Amortizatization of Intangibles (2020 - 2023)
ADC Therapeutics (ADCT) posted quarterly Amortizatization of Intangibles of $52000.0 for Q3 2023, up 67.74% year-on-year from $31000.0 in Q3 2022, and up 1.96% on a QoQ basis from $51000.0 in Q2 2023.
ADC Therapeutics (ADCT) Amortizatization of Intangibles (2020 - 2023) Analysis & Trends
ADC Therapeutics (ADCT) has reported Amortizatization of Intangibles for 4 consecutive years, with $52000.0 the latest figure, recorded in Q3 2023.
- Quarterly Amortizatization of Intangibles rose 67.74% year-over-year to $52000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $185000.0 (up 52.89% YoY) and the FY2022 annual result came in at $118000.0, down 8.53% from the prior year.
- Amortizatization of Intangibles advanced to $52000.0 in Q3 2023 per ADCT's latest filing, from $51000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for ADCT reached as high as $52000.0 in Q1 2023 and fell as low as $8000.0 in Q2 2020.
- A 4-year average of $29933.3 and a median of $31000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles soared 375.0% — and 2022, when it dropped 18.42%.
- Year by year, Amortizatization of Intangibles stood at $19000.0 in 2020, then surged by 73.68% to $33000.0 in 2021, then retreated by 9.09% to $30000.0 in 2022, then soared by 73.33% to $52000.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $52000.0, $51000.0, and $52000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | ADC Therapeutics | 174.95 Mn | -56.06 Mn | 17.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Mar 31, 2023 | 52,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Dec 31, 2021 | 33,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Jun 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 38,000.00 |